Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
News|Articles|July 7, 2025

Success Guide – Marketing’s Final Mile

Author(s)ACTO

Explore how pharma marketers can bridge the gap between brand strategy and field execution to drive HCP engagement, compliance, and ROI.

Get the Guide

Whitepapers

Related Content

Navigating Sunshine Act & State Transparency Laws

May 6th 2026

The RWE Backlog Problem

ByHealthVerity
May 4th 2026

Accelerating early RWE exploration without increasing analytic burden

ByHealthVerity
May 4th 2026

Validating HealthVerity eXOs: An agentic AI platform for real-world evidence

ByHealthVerity
May 4th 2026

The Ways Pharma Leaders are Rewiring their Organizations for Launch Success

ByInizio
March 31st 2026

Trending on PharmExec

1

Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables

2

Pharmaceutical Executive Daily: Rigel Pharmaceuticals Enters an Exclusive Global Licensing Agreement with Arvinas and Pfizer for Veppanu

3

Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu

4

Beyond the Molecule: The New Competitive Battlefield in Oncology

5

Being an Expert Is About More Than Just Knowing the Answers

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us